Palvella Therapeutics, Inc.
USD157.24
+9.47 (+6.41%)
CEO
Wesley H. Kaupinen
IPO Date
2015-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$147.39
Prev. Close
$147.77
Day Low
$145.79
Day High
$158.08
52W Low
$29.59
52W High
$161.38
Market Cap
$1.86B
Volume
0.26M
| 2,148 |
| $9.08 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | S-Sale | Disposed | 522 | $147.14 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | S-Sale | Disposed | 840 | $148.40 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | S-Sale | Disposed | 1,029 | $149.27 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | S-Sale | Disposed | 1,911 | $150.25 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | M-Exempt | Disposed | 2,154 | $7.14 |
| 17 Jul 2026 | Goin Kathleen | Chief Operating Officer | M-Exempt | Disposed | 2,148 | $9.08 |
| 1 Jul 2026 | Pauls Matthew | director | A-Award | Acquired | 6,000 | $154.84 |
| 1 Jul 2026 | Pauls Matthew | director: | Disposed | 0 | $0.00 |